Canadian drug price regulator may be flexible on rare diseases

Canada’s patented drug price regulator, set to gain new powers next year, may be “more forgiving” in setting price caps for drugs that treat rare diseases, the agency’s executive director told Reuters, as some advocates warned the country’s pricing reforms would hurt patients.


Read More

Uncategorized

Leave a Reply and send us your feed back

This site uses Akismet to reduce spam. Learn how your comment data is processed.